Cue Biopharma, Inc.

US$18.73As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:CUEHealthcare
Country USA
PE (Fwd) •••
TSR 9Y CAGR (30.49%)
Div yield —
ROE (1603.48%)
Biotechnology
Beta (5Y) 2.81
PE TTM —
TSR TTM (18.66%)
Mkt cap US$136.1M
ROIC (395.46%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$19
3.40%
226.78%
Hold 11|3|3|2|4
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.44
0.45
0.46
0.45
19.19%
16.57%
16.60%
1.22%
Revenue$M
5.969
6.178
6.206
6.071
(1.26%)
4.90%
2.03%
0.16%
Peers (US$136.1M)
Cap (US$)
PE
Capital
TTM
5Y
10Y
Leveragex
4.302
—
—
EBIT/Intx
0.930
0.048
0.045
Own earn%
5.59
3.57
5.54
Sh yield%
10.57
29.19
26.59
Owners
Insiders/Inst%
0.55
58.88
Short interest%
4.08
SBC / revenue%
3.01
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
10
Op margin range%
2–8
$1 testx
0.0
Incr. ROIC%
18